REGN | Regeneron Pharmaceuticals
571.75 -3.73 (-0.65%)
REGN Price Profile
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Regeneron Pharmaceuticals (REGN) company profile
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products to treat severe medical conditions. Some of the firm’s products include EYLEA injection and ARCALYST injection. The company’s commercialized medicines are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, infectious diseases, and other rare diseases.